Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Multi-Center, Open Label, Forced Titration Study To Evaluate The Efficacy, Safety, And Tolerability Of Torcetrapib/Atorvastatin Combination Administered Orally, Once Daily (Qd) In Patients With Homozygous Familial Hypercholesterolaemia

NCT00134511 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00134511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00134511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Multi-Center, Open Label, Forced Titration Study To Evaluate The Efficacy, Safety, And Tolerability Of Torcetrapib/Atorvastatin Combination Administered Orally, Once Daily (Qd) In Patients With Homozygous Familial Hypercholesterolaemia
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2005
Completion date
November 30, 2005
Enrollment
30
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia, familial